For instance, local and systemic inflammation induced by IL-1 underlay a broad list of diseases, ranging from rheumatic diseases and autoinflammatory syndromes to cardiovascular diseases, type 2 diabetes, and infections and sepsis, and targeting of IL-1 has relevant therapeutic implications (24–27). This evidence concerns the gene IL1B and infection.